InsidersTradesSigma
Track the Lomond Therapeutics Holdings, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 5 November 2024 (C). Among the most active insiders: Savchuk Nikolay. Every trade is accessible without an account.
Analysts rate Lomond Therapeutics Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Lomond Therapeutics Holdings, Inc. es una empresa que cotiza en el mercado XNAS, centrada en el desarrollo de terapias innovadoras. Se especializa en la investigación y el desarrollo de soluciones terapéuticas para enfermedades específicas.